Spironolactone is a diuretic medication, sold under the brand name Aldactone among others. It is used to treat fluid build-up from liver or kidney disease and to reduce the risk of progression, hospitalization and death in some types of heart failure. Other uses include acne and excessive hair growth in women, low blood potassium that does not respond to supplements, hard-to-treat high blood pressure, early puberty in boys, and blocking testosterone as part of feminizing hormone therapy, a use with a long history in the trans community. It is a steroid that blocks aldosterone and, to a lesser degree, testosterone, and belongs to the potassium-sparing diuretics. Tablets taken by mouth are usual, though topical forms exist. Common side effects include electrolyte abnormalities, particularly high blood potassium, nausea, headache and rashes. It was discovered in 1957, introduced in 1959, is on the World Health Organization List of Essential Medicines and is sold as a generic. This is a record of what is held about the drug, not medical advice.
Facts
Classification
Approval Status ATC ClassC: Cardiovascular System 2 Route of Administration Route of Administration WHO Essential Medicine First Approved / Isolated Year Sources
1. ChEMBL, EMBL-EBI: ChEMBL molecule record for Spironolactone
ChEMBL, EMBL-EBImolecule record: max_phaseQuote, molecule record: max_phase
"max_phase": "4.0"
View the Source 2. RxNav RxClass, National Library of Medicine: RxClass ATC classes of Spironolactone
RxNav RxClass, National Library of MedicineRxClass ATC class of the drug (levels 1 to 4); ATC class derived from cited code C03DA (main group C)Quote, RxClass ATC class of the drug (levels 1 to 4); ATC class derived from cited code C03DA (main group C)
"classId": "C03DA", "className": "Aldosterone antagonists", "classType": "ATC1-4"
View the Source 3. Spironolactone (Wikipedia)
Lead section of the English Wikipedia article
Spironolactone was discovered in 1957, and was introduced in 1959.
Lead section of the English Wikipedia article [route-of-administration]
Spironolactone is usually available in tablets, taken by mouth, though topical forms are also available.
View the Source4. World Health Organization: The selection and use of essential medicines, 2025: WHO Model List of Essential Medicines, 24th list
World Health OrganizationPDF page 47; section 12.4; the entry spironolactone is in the Core List of the WHO Model List of Essential Medicines, 24th list (2025)Quote, PDF page 47; section 12.4; the entry spironolactone is in the Core List of the WHO Model List of Essential Medicines, 24th list (2025)
spironolactone Injection: 100 micrograms/mL in 1 mL ampoule;
View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.